Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

OBJECTIVEThis study aims to assess the validity of the ADHD module of the Mini-International Neuropsychiatric Interview (MINI-Plus) in patients with substance use disorders (SUD), using the Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as the external criterion.METHODA cross sect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH 2023-01, Vol.16 (1), p.11-15
Hauptverfasser: Palma-Álvarez, Raul Felipe, Barta, Csaba, Carpentier, Pieter Jan, Carruthers, Susan, Crunelle, Cleo L., Demetrovics, Zsolt, Dom, Geert, Faraone, Stephen V., Franck, Johan, Johnson, Brian, Kapitány-Fövény, Máté, Kaye, Sharlene, Konstenius, Maija, Matthys, Frieda, Moggi, Franz, Møller, Merete, Schellekens, Arnt, Skutle, Arvid, van de Glind, Geurt, van Emmerik-van Oortmerssen, Katelijne, Verspreet, Sofie, Schoevers, Robert A., Wallhed, Sara, Levin, Frances R., Grau-López, Lara, Casas, Miguel, van den Brink, Wim, Ramos-Quiroga, Josep Antoni
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVEThis study aims to assess the validity of the ADHD module of the Mini-International Neuropsychiatric Interview (MINI-Plus) in patients with substance use disorders (SUD), using the Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as the external criterion.METHODA cross sectional international multi-center study in 10 countries was conducted in treatment seeking SUD patients. A sample of 1263 patients with both MINI-Plus and CAADID was analyzed to determine the psychometric properties of the MINI-Plus.RESULTSAccording to the CAADID, 179 patients (14.2%) met criteria for adult ADHD, whereas according to the MINI-Plus 227 patients (18.0%) were identified as having adult ADHD. Sensitivity of the MINI-Plus ADHD module was 74%, specificity was 91%, positive predictive value was 60% and negative predictive value was 96%. Kappa was 0.60.CONCLUSIONThe MINI-Plus has acceptable criterion validity for the screening of adult ADHD in treatment seeking SUD patients.SCIENTIFIC SIGNIFICANCEOn the basis of the results, The MINI-Plus may be used for the screening of ADHD in SUD patients.
ISSN:2950-2853
2950-2861
2950-2853
DOI:10.1016/j.rpsm.2020.04.013